Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

OBJECTIVES: Patients with rheumatoid arthritis (RA) are at increased risk of lymphoma compared with the general population. There are concerns that tumour necrosis factor inhibitors (TNFi) may exacerbate this risk. However, since the excess risk of lymphoma in RA is related to the cumulative burden...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercer, Louise K, Galloway, James B, Lunt, Mark, Davies, Rebecca, Low, Audrey L S, Dixon, William G, Watson, Kath D, Symmons, Deborah P M, Hyrich, Kimme L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446004/
https://www.ncbi.nlm.nih.gov/pubmed/27502891
http://dx.doi.org/10.1136/annrheumdis-2016-209389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446004/
https://www.ncbi.nlm.nih.gov/pubmed/27502891
http://dx.doi.org/10.1136/annrheumdis-2016-209389

Ejemplares similares